The UK National Contact Person (NCP) for Pharmacovigilance plays a critical role in ensuring compliance with evolving UK regulations post-Brexit. The NCP acts as the designated point of contact between the Marketing Authorisation Holder (MAH) and the Medicines and Healthcare products Regulatory Agency (MHRA), especially when the Qualified Person for Pharmacovigilance (QPPV) is based in the EU or EEA.
Key Responsibilities of the UK NCP
The UK NCP must reside and operate in the UK and report directly to the QPPV, ensuring seamless regulatory communication.
This individual has access to UK adverse event reports and the Pharmacovigilance System Master File (PSMF) relevant to UK-authorised products, making them pivotal for inspection readiness and real-time compliance.
The UK NCP facilitates timely responses to MHRA pharmacovigilance queries and supports inspections, acting as the "postbox" for regulatory communications but with much broader potential for strategic contribution.
How the UK NCP Adds Value
Beyond mandatory duties, value-adding UK NCPs actively participate in creating and maintaining the PSMF and the pharmacovigilance quality management system, drawing on experience to optimise processes and documentation standards.
They support the QPPV with documentation review, regulatory intelligence, and strategic decision-making in cross-functional meetings, such as Safety Boards and Compliance Committees.
Acting as a source of UK-specific regulatory intelligence, the NCP can provide regular updates to senior management and ensure the company remains ahead of changes affecting pharmacovigilance obligations.
Compliance and Operational Insights
Appointment of the UK NCP must be notified via the MHRA Submission Portal, with procedures in place for covering periods of absence longer than one month.
There’s no requirement for 24/7 NCP availability, but timely responsiveness during UK business hours is expected.
Best practice is to select a UK NCP with extensive pharmacovigilance experience, enabling proactive compliance and business continuity.
By leveraging a value-driven UK NCP, pharma companies enhance their regulatory compliance, streamline communication with the MHRA, and maintain an agile approach toward the UK’s dynamic pharmacovigilance environment.
How We Can Help
PharmaGuard Consultancy Ltd is uniquely positioned to support pharmaceutical seeking assistance with establishing a value adding NCP. Our experienced team can guide you through the regulatory landscape, from strategy to execution, ensuring your company remains fully compliant and your patients protected.
👉 Get in touch to explore how our pharmacovigilance and compliance expertise can strengthen your next move.